News

With the wide variety of stocks in the market, it can be tough to narrow your focus to those that possess long-term potential. That's exactly what you need to do, though, to help to grow your

Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) stock cut his price target on the pharmaceutical giant. Even though that

Predicting that a stock will double in a certain time frame is a bold call, but predicting it will happen within two-and-a-half years is an even bolder take. However, I think that SoundHound AI

Warren Buffett is widely considered to be the most successful investor of the modern era, having delivered total returns of more than 6,000,000% in about six decades at the helm of Berkshire

The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100 billion by 2030. As a result, many top healthcare companies are vying for a

The stock market hasn't exactly performed well recently. As I write this on April 22, the S&P 500 remains about 15% below its recent high, and the Nasdaq Composite index remains down 20%, in bear

Natural gas pipeline giant Kinder Morgan (NYSE: KMI) has long held an optimistic view on the future of natural gas demand. The company believes that liquified natural gas (LNG) exports will drive

President Donald Trump's tariffs have spooked the stock market. It is unclear what comes next in the trade war with China and other countries versus the U.S., with potentially large effects on

Tesla (NASDAQ:TSLA), the renowned leader in electric vehicles and sustainable energy, released its earnings report on April 22, 2025, for the first quarter of 2025.

The release highlighted a

Investors expected disappointing results when Tesla (NASDAQ: TSLA) reported earnings Tuesday afternoon. Unfortunately, that's pretty much what they got. Revenue and earnings plummeted as the company

First-quarter earnings are starting to roll out, with some companies already reporting. However, we're just starting to get to the point where the big tech companies are releasing results, and their

The greatest investor of our time -- besides you, of course -- owns a public portfolio of more than three dozen stocks. One name that I think can deliver big gains from today's starting line is

Iovance Biotherapeutics (NASDAQ: IOVA) is a stock that many investors think has a lot of upside. A year ago, regulators approved its cellular therapy, Amtagvi, to treat unresectable (inoperable) or

If you're 66 now, you were probably born around 1959 -- the year that Alaska and Hawaii became states, and the Barbie doll debuted. You're probably approaching or are in retirement, and you may be

The U.S. equity market enjoyed impressive rallies in 2023 and 2024, fueled mainly by optimism around artificial intelligence (AI). However, 2025 is proving to be a different story as markets grapple

Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results -- though strong by comparison to most of its peers -- haven't been as

As Shiba Inu (CRYPTO: SHIB) approaches the fifth anniversary of its August 2020 launch, it stands as a surprising success story in the volatile cryptocurrency landscape. The project has grown into a

Nobody has more information about a company than its insiders, especially its executive management team. That's why when one of them buys more shares, it sometimes gives individual investors

Ford (NYSE: F) is at the epicenter of rising tariffs, and the business could face enormous consequences.

*Stock prices used were the afternoon prices of April 20, 2025. The video was published on

Between the uncertainty caused by President Donald Trump's tariff policy, consumers being increasingly reluctant to spend on discretionary purchases, and several other factors, a U.S. recession in

Why do you invest? For most people, their primary goal is to build a nice-sized retirement nest egg. And that's a worthy aim, to be sure.

There's nothing wrong with thinking bigger, though. What if

Investment management firm Vanguard has around 50 equity-focused exchange-traded funds (ETFs) with ultra-low expense ratios. These funds offer simple ways to invest in dozens or even thousands of

Investing in emerging industries like artificial intelligence (AI) can be risky. Past technology booms have taught investors that not every company survives, and picking the winners and losers isn't

While there are only three major wireless providers in the United States, competition can be fierce. Verizon (NYSE: VZ) scored a win in the fourth quarter of last year with significant consumer

Type 2 diabetes and obesity have become an increasing global healthcare problem, reaching near crisis proportions in the United States. The arrival of GLP-1 agonists, drugs that mimic hormones to